{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:30:27Z","timestamp":1788291027488,"version":"build-2803163510"},"reference-count":45,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Res (Stuttg)"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Therapeutic drug monitoring investigations based on saliva samples can be\n                    utilized as an alternative to blood sampling for many advantages. Moreover, the\n                    development of physiologically based pharmacokinetic (PBPK) modeling tools can\n                    further help to estimate drug exposure from saliva. This review discusses the\n                    use of saliva samples and illustrates the applications and examples of PBPK\n                    modeling systems for estimating drug exposure from saliva.<\/jats:p>","DOI":"10.1055\/a-1956-9313","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:56:54Z","timestamp":1668214614000},"page":"65-69","source":"Crossref","is-referenced-by-count":15,"title":["Saliva Sampling in Therapeutic Drug Monitoring and Physiologically\n                    Based Pharmacokinetic Modeling: Review"],"prefix":"10.1055","volume":"73","author":[{"given":"May","family":"Almukainzi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, Princess\n                    Nourah bint Abdulrahman University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"p. 1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of Therapeutic Drug Monitoring","volume":"24","author":"J-S Kang","year":"2009","journal-title":"Korean J. Intern. Med., vol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25174026","article-title":"Review of Chromatographic Methods Coupled with Modern Detection Techniques\n                    Applied in the Therapeutic Drugs Monitoring (TDM)","volume":"25","author":"T Tuzimski","year":"2020","journal-title":"Molecules, vol., vol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"pp. 1037","DOI":"10.4155\/bio.15.35","article-title":"Alternative matrices for therapeutic drug monitoring of immunosuppressive agents\n                    using LC-MS\/MS","volume":"7","author":"M Ghareeb","year":"2015","journal-title":"Bioanalysis, vol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"pp. 823","DOI":"10.7150\/ijms.25146","article-title":"Compliance with Saliva Collection Protocol in Healthy Volunteers: Strategies for\n                    Managing Risk and Errors","volume":"15","author":"KR Bhattarai","year":"2018","journal-title":"Int. J. Med. Sci., vol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1863157\/v1","article-title":"Associations between saliva and plasma cytokines and YKL-40 in\n                    cognitively-normal, older adults","author":"G Parkin","year":"2022","journal-title":"Research Square"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"p. 7371","DOI":"10.1038\/s41598-018-25095-3","article-title":"Salivary levels of total huntingtin are elevated in Huntington\u2019s disease\n                    patients","volume":"8","author":"J Corey-Bloom","year":"2018","journal-title":"Sci. Rep., vol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"pp. 1","DOI":"10.3389\/fnmol.2019.00335","article-title":"Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived\n                    Neurotrophic Factor (BDNF) as a Biomarker in Huntington\u2019s Disease\n                    Patients","volume":"12","author":"A Gutierrez","year":"2020","journal-title":"Front. Mol. Neurosci., vol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165898","article-title":"Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug\n                    Administration in Neonates Using New Techniques: An Overview on the\n                    Pharmacokinetics and Pharmacodynamics in Neonatal Age","volume":"21","author":"DU De Rose","year":"2020","journal-title":"International Journal of Molecular Sciences, vol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"pp. 561","DOI":"10.1007\/s002280000179","article-title":"Use of saliva and capillary blood samples as substitutes for venous blood\n                    sampling in pharmacokinetic investigations of artemisinin","volume":"56","author":"T Gordi","year":"2000","journal-title":"Eur. J. Clin. Pharmacol., vol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"pp. 1089","DOI":"10.1111\/bcp.13553","article-title":"A descriptive systematic review of salivary therapeutic drug monitoring in\n                    neonates and infants","volume":"84","author":"L Hutchinson","year":"2018","journal-title":"Br. J. Clin. Pharmacol., vol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"pp. 1","DOI":"10.3389\/fphar.2021.755184","article-title":"A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological\n                    Fluids: The Salivary Therapeutic Drug Monitoring","volume":"12","author":"V Avataneo","year":"2022","journal-title":"Front. Pharmacol., vol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"pp. 679","DOI":"10.1111\/bdi.13128","article-title":"Saliva testing as a means to monitor therapeutic lithium levels in patients with\n                    psychiatric disorders: Identification of clinical and environmental covariates,\n                    and their incorporation into a prediction model","volume":"23","author":"GM Parkin","year":"2021","journal-title":"Bipolar Disord., vol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00894","article-title":"Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for\n                    Voriconazole Based on a Systematic Review","volume":"11","author":"HY Kim","year":"2020","journal-title":"Front. Pharmacol., vol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva","volume":"35","author":"PN Patsalos","year":"2013","journal-title":"Ther. Drug Monit., vol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"pp. 61","DOI":"10.1093\/jat\/bky064","article-title":"Determination of antiepileptic drugs using dried saliva spots","volume":"43","author":"J Carvalho","year":"2019","journal-title":"J. Anal. Toxicol., vol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01903-2019","article-title":"Therapeutic drug monitoring using saliva as matrix: An opportunity for\n                    linezolid, but challenge for moxifloxacin","volume":"55","author":"SHJ Van Den Elsen","year":"2020","journal-title":"Eur. Respir. J., vol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"pp. 1","DOI":"10.19080\/NAPDD.2018.04.555632","article-title":"Saliva versus Blood Therapeutic Drug Monitoring of Tacrolimus in Jordanian\n                    Kidney Transplant Patients","author":"S Hamadi","year":"2018"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"pp. 2358","DOI":"10.1021\/mp300250r","article-title":"Saliva versus Plasma Pharmacokinetics: Theory and Application of a Salivary\n                    Excretion Classification System","volume":"9","author":"N Idkaidek","year":"2012","journal-title":"Mol. Pharm., vol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"pp. e02379","DOI":"10.1128\/AAC.02379-18","article-title":"Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic\n                    Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant\n                    Tuberculosis","volume":"63","author":"G Samiksha","year":"2019","journal-title":"Antimicrob. Agents Chemother., vol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"pp. 564","DOI":"10.1097\/FTD.0000000000000831","article-title":"Relationship Between Amphetamine Concentrations in Saliva and Serum in Children\n                    and Adolescents With Attention-Deficit\/Hyperactivity Disorder","volume":"43","author":"C Wohkittel","year":"2021","journal-title":"Ther. Drug Monit., vol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030641","article-title":"Stability of Cocaine, Opiates, and Metabolites in Dried Saliva Spots","volume":"27","author":"E Almeida","year":"2022","journal-title":"Molecules, vol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2021.11.001","article-title":"Potential use of a dried saliva spot (DSS) in therapeutic drug monitoring and\n                    disease diagnosis","author":"Y Han","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"pp. 1906","DOI":"10.1111\/1556-4029.14112","article-title":"Development and Validation of a Method Using Dried Oral Fluid Spot to Determine\n                    Drugs of Abuse","volume":"64","author":"ALB Jacques","year":"2019","journal-title":"J. Forensic Sci., vol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"pp. 1262","DOI":"10.1016\/j.tibtech.2020.03.001","article-title":"On-Site Therapeutic Drug Monitoring","volume":"38","author":"HC Ates","year":"2020","journal-title":"Trends Biotechnol., vol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.12.004","article-title":"Disease specific modeling: Simulation of the pharmacokinetics of meloxicam and\n                    ibuprofen in disease state vs. healthy conditions","volume":"100","author":"M Almukainzi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm., vol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.09.036","article-title":"The Irrelevance of In Vitro Dissolution in Setting Product Specifications for\n                    Drugs Like Dextromethorphan That are Subject to Lysosomal Trapping","volume":"108","author":"MB Bolger","year":"2019","journal-title":"J. Pharm. Sci., vol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-017-0307-y","article-title":"Mechanistic understanding of the effect of renal impairment on metformin oral\n                    absorption using computer simulations","volume":"47","author":"M Almukainzi","year":"2017","journal-title":"J. Pharm. Investig., vol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000353","article-title":"Modelling the Absorption of Metformin with Patients Post Gastric Bypass\n                    Surgery","volume":"05","author":"M Almukainzi","year":"2014","journal-title":"J. Diabetes Metab., vol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"pp. 1","DOI":"10.7939\/R3QR4P28H","article-title":"The application of computer simulation to investigate drug absorption and\n                    bioavailability in disease states","author":"M. Almukainzi","year":"2016"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"p. 106258","DOI":"10.1016\/j.ejps.2022.106258","article-title":"Physiologically based pharmacokinetic modeling of brivaracetam and its\n                    interactions with rifampin based on CYP2C19 phenotypes","author":"H Yang","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"pp. 919","DOI":"10.1002\/psp4.12807","article-title":"Robust physiologically based pharmacokinetic model of rifampicin for predicting\n                    drug-drug interactions via P-glycoprotein induction and inhibition in the\n                    intestine, liver, and kidney","author":"R Asaumi","year":"2022","journal-title":"CPT Pharmacometrics Syst. Pharmacol., no. April"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071474","article-title":"A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4\n                    Substrate Felodipine for Drug&ndash;Drug Interaction Modeling","volume":"14","author":"LM Fuhr","year":"2022","journal-title":"Pharmaceutics, vol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"pp. 55","DOI":"10.1002\/bdd.1767","article-title":"Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with\n                    our needs?","volume":"33","author":"F Bouzom","year":"2012","journal-title":"Biopharm. Drug Dispos., vol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.37","volume":"97","author":"HM Jones","year":"2015","journal-title":"Physiologically Based Pharmacokinetic Modeling in Drug Discovery and\n                    Development: A Pharmaceutical Industry Perspective,\u201d vol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"pp. 107","DOI":"10.1002\/bdd.2257","article-title":"Physiological-based pharmacokinetic modeling trends in pharmaceutical drug\n                    development over the last 20-years; in-depth analysis of applications,\n                    organizations, and platforms","volume":"42","author":"E El-Khateeb","year":"2021","journal-title":"Biopharm. Drug Dispos., vol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/a-1852-5391","article-title":"Therapeutic Drug Monitoring of Vancomycin in Jordanian Patients. Development of\n                    Physiologically-Based Pharmacokinetic (PBPK) Model and Validation of Class II\n                    Drugs of Salivary Excretion Classi\ufb01cation System (SECS)","author":"M Arabyat","year":"2022","journal-title":"Drug Res, no. EFirst"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"pp. 754","DOI":"10.1111\/bcp.13001","article-title":"Salivary caffeine concentrations are comparable to plasma concentrations in\n                    preterm infants receiving extended caffeine therapy","volume":"82","author":"NR Dobson","year":"2016","journal-title":"Br. J. Clin. Pharmacol., vol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"pp. 54","DOI":"10.1055\/s-0043-117775","article-title":"Saliva versus Plasma Bioequivalence of Valsartan\/Hydrochlorothiazide in\n                    Humans: Validation of Classes II and IV Drugs of the Salivary Excretion\n                    Classification System","volume":"68","author":"N Idkaidek","year":"2018","journal-title":"Drug Res. (Stuttg)., vol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"pp. 704","DOI":"10.2174\/1871527320666210621102437","article-title":"The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva\n                    and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney\n                    Function","volume":"21","author":"MM Alsmadi","year":"2022","journal-title":"CNS & Neurological Disorders \u2013 Drug Targets,\n                    vol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"pp. 455","DOI":"10.1055\/a-1233-358","article-title":"Saliva versus Plasma Therapeutic Drug Monitoring of Gentamicin in Jordanian\n                    Preterm Infants. Development of a Physiologically-Based Pharmacokinetic (PBPK)\n                    Model and Validation of Class II Drugs of Salivary Excretion Classification\n                    System","volume":"70","author":"N Idkaidek","year":"2020","journal-title":"Drug Res, vol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"pp. 295","DOI":"10.1080\/15298660108984631","article-title":"Development of an Integrated Microanalytical System for Analysis of Lead in\n                    Saliva and Linkage to a Physiologically Based Pharmacokinetic Model Describing\n                    Lead Saliva Secretion","volume":"62","author":"C Timchalk","year":"2001","journal-title":"AIHAJ \u2013 Am. Ind. Hyg. Assoc., vol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"pp. 635","DOI":"10.1080\/15287390490428035","article-title":"Noninvasive Biomonitoring Approaches to Determine Dosimetry and Risk Following\n                    Acute Chemical Exposure: Analysis of Lead or Organophosphate Insecticide in\n                    Saliva","volume":"67","author":"C Timchalk","year":"2004","journal-title":"J. Toxicol. Environ. Heal. Part A, vol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"pp. 325","DOI":"10.1002\/bdd.2206","article-title":"The development of a population physiologically based pharmacokinetic model for\n                    mycophenolic mofetil and mycophenolic acid in humans using data from plasma,\n                    saliva, and kidney tissue","volume":"40","author":"MM Alsmadi","year":"2019","journal-title":"Biopharm. Drug Dispos., vol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"p. 125","DOI":"10.1208\/s12248-020-00481-w","article-title":"Incorporating Pharmacological Target-Mediated Drug Disposition (TMDD) in a\n                    Whole-Body Physiologically Based Pharmacokinetic (PBPK) Model of Linagliptin in\n                    Rat and Scale-up to Human","volume":"22","author":"N Wu","year":"2020","journal-title":"AAPS J., vol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"pp. 3","DOI":"10.1590\/0103-6440202104059","article-title":"Pharmacogenetic and pharmacokinetic assays from saliva samples can guarantee\n                    personalized drug prescription","volume":"32","author":"B Bolani","year":"2021","journal-title":"Braz. Dent. J., vol"}],"container-title":["Drug Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1956-9313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:44:02Z","timestamp":1675730642000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1956-9313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":45,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1956-9313","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2194-9379","2194-9387"],"issn-type":[{"value":"2194-9379","type":"print"},{"value":"2194-9387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}